Australia markets open in 5 hours 24 minutes

Anatara Lifesciences Ltd (ANR.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.02800.0000 (0.00%)
At close: 10:57AM AEDT
Currency in AUD

Valuation measures4

Market cap (intra-day) 3.36M
Enterprise value 2.07M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)6.31
Price/book (mrq)1.96
Enterprise value/revenue 1.95
Enterprise value/EBITDA -0.91

Trading information

Stock price history

Beta (5Y monthly) 0.83
52-week change 3-68.89%
S&P500 52-week change 3-12.41%
52-week high 30.1000
52-week low 30.0270
50-day moving average 30.0347
200-day moving average 30.0467

Share statistics

Avg vol (3-month) 352.63k
Avg vol (10-day) 3147.48k
Shares outstanding 5119.92M
Implied shares outstanding 6N/A
Float 889.19M
% held by insiders 127.24%
% held by institutions 18.89%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2022
Most-recent quarter (mrq)31 Dec 2022


Profit margin 0.00%
Operating margin (ttm)-2,975.66%

Management effectiveness

Return on assets (ttm)-56.46%
Return on equity (ttm)-105.17%

Income statement

Revenue (ttm)77.15k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)24.20%
Gross profit (ttm)-747.18k
Net income avi to common (ttm)-2.29M
Diluted EPS (ttm)-0.0300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.4M
Total cash per share (mrq)0.01
Total debt (mrq)55.62k
Total debt/equity (mrq)3.24
Current ratio (mrq)9.16
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-2.38M
Levered free cash flow (ttm)-1.53M